1. Home
  2. AVO vs ODTX Comparison

AVO vs ODTX Comparison

Compare AVO & ODTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mission Produce Inc.

AVO

Mission Produce Inc.

HOLD

Current Price

$13.13

Market Cap

1.2B

ML Signal

HOLD

Logo Odyssey Therapeutics Inc. Common Stock

ODTX

Odyssey Therapeutics Inc. Common Stock

N/A

Current Price

$25.15

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AVO
ODTX
Founded
1983
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2020
2025

Fundamental Metrics

Financial Performance
Metric
AVO
ODTX
Price
$13.13
$25.15
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$17.00
N/A
AVG Volume (30 Days)
656.0K
126.1K
Earning Date
06-04-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
1.92
N/A
EPS
N/A
N/A
Revenue
$1,391,200,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.06
N/A
P/E Ratio
N/A
N/A
Revenue Growth
12.68
N/A
52 Week Low
$10.07
$15.10
52 Week High
$15.53
$26.49

Technical Indicators

Market Signals
Indicator
AVO
ODTX
Relative Strength Index (RSI) 54.40 71.31
Support Level $13.03 $19.84
Resistance Level $14.11 N/A
Average True Range (ATR) 0.42 1.88
MACD 0.02 0.53
Stochastic Oscillator 73.79 75.94

Price Performance

Historical Comparison
AVO
ODTX

About AVO Mission Produce Inc.

Mission Produce Inc produces, packs, and distributes mainly Hass avocados to retail, wholesale, and food service customers, offering pre-ripe and ripened fruit tailored to customer specifications through its network of ripening facilities. The Company operates through three segments: Marketing & Distribution, which sources and distributes fruit globally and generates the majority of revenue; International Farming, which owns and operates avocado orchards and supplies fruit mainly to Marketing & Distribution, with operations principally in Peru and Guatemala; and Blueberries, which farms blueberries sold under an exclusive marketing agreement. The Company's operations span Peru, the United States, Guatemala, Mexico, Europe, and Canada.

About ODTX Odyssey Therapeutics Inc. Common Stock

Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases. The Company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.

Share on Social Networks: